# Lecanemab for Early Onset Familial Alzheimer's Disease

> **NCT06883019** · — · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 114 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06883019
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-13
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-08-31
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06883019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06883019, "Lecanemab for Early Onset Familial Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06883019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*